BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Julphar
Covington
Merck
US Army
Accenture
Harvard Business School
Novartis
Cerilliant
AstraZeneca

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086195

« Back to Dashboard

NDA 086195 describes PROCTOFOAM HC, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from three suppliers. Additional details are available on the PROCTOFOAM HC profile page.

The generic ingredient in PROCTOFOAM HC is hydrocortisone acetate; pramoxine hydrochloride. There are sixty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate; pramoxine hydrochloride profile page.
Summary for 086195
Tradename:PROCTOFOAM HC
Applicant:Mylan Speciality Lp
Ingredient:hydrocortisone acetate; pramoxine hydrochloride
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 086195
Suppliers and Packaging for NDA: 086195
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCTOFOAM HC hydrocortisone acetate; pramoxine hydrochloride AEROSOL, METERED;TOPICAL 086195 ANDA Meda Pharmaceuticals 0037-6822 0037-6822-10 1 CANISTER in 1 CARTON (0037-6822-10) > 10 g in 1 CANISTER
PROCTOFOAM HC hydrocortisone acetate; pramoxine hydrochloride AEROSOL, METERED;TOPICAL 086195 ANDA Rebel Distributors Corp 21695-982 21695-982-10 1 CONTAINER in 1 CARTON (21695-982-10) > 10 g in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;TOPICALStrength1%;1%
Approval Date:Approved Prior to Jan 1, 1982TE:BXRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
McKesson
QuintilesIMS
Express Scripts
Harvard Business School
Dow
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot